• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏代谢:健康与患病心脏之间的连锁谜题——治疗应用的新前沿

Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.

作者信息

Pasqua Teresa, Rocca Carmine, Giglio Anita, Angelone Tommaso

机构信息

Department of Health Science, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.

Laboratory of Cellular and Molecular Cardiovascular Pathophysiology, Department of Biology, E. and E.S. (Di.B.E.S.T.), University of Calabria, 87036 Rende (CS), Italy.

出版信息

J Clin Med. 2021 Feb 12;10(4):721. doi: 10.3390/jcm10040721.

DOI:10.3390/jcm10040721
PMID:33673114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7918460/
Abstract

Cardiac metabolism represents a crucial and essential connecting bridge between the healthy and diseased heart. The cardiac muscle, which may be considered an omnivore organ with regard to the energy substrate utilization, under physiological conditions mainly draws energy by fatty acids oxidation. Within cardiomyocytes and their mitochondria, through well-concerted enzymatic reactions, substrates converge on the production of ATP, the basic chemical energy that cardiac muscle converts into mechanical energy, i.e., contraction. When a perturbation of homeostasis occurs, such as an ischemic event, the heart is forced to switch its fatty acid-based metabolism to the carbohydrate utilization as a protective mechanism that allows the maintenance of its key role within the whole organism. Consequently, the flexibility of the cardiac metabolic networks deeply influences the ability of the heart to respond, by adapting to pathophysiological changes. The aim of the present review is to summarize the main metabolic changes detectable in the heart under acute and chronic cardiac pathologies, analyzing possible therapeutic targets to be used. On this basis, cardiometabolism can be described as a crucial mechanism in keeping the physiological structure and function of the heart; furthermore, it can be considered a promising goal for future pharmacological agents able to appropriately modulate the rate-limiting steps of heart metabolic pathways.

摘要

心脏代谢是健康心脏与患病心脏之间至关重要且必不可少的连接桥梁。心肌在能量底物利用方面可被视为一种杂食性器官,在生理条件下主要通过脂肪酸氧化获取能量。在心肌细胞及其线粒体内,通过协调良好的酶促反应,底物汇聚于三磷酸腺苷(ATP)的生成,ATP是心肌将其转化为机械能(即收缩)的基本化学能量。当内环境稳态受到干扰时,如发生缺血事件,心脏会被迫将基于脂肪酸的代谢转换为碳水化合物利用,作为一种保护机制,以维持其在整个机体中的关键作用。因此,心脏代谢网络的灵活性深刻影响心脏通过适应病理生理变化做出反应的能力。本综述的目的是总结在急性和慢性心脏疾病状态下心脏中可检测到的主要代谢变化,分析可能的治疗靶点。在此基础上,心脏代谢可被描述为维持心脏生理结构和功能的关键机制;此外,它可被视为未来能够适当调节心脏代谢途径限速步骤的药物的一个有前景的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/c5cd660b9ec2/jcm-10-00721-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/c2c7a6fe5e11/jcm-10-00721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/e3c9e18f6538/jcm-10-00721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/c5cd660b9ec2/jcm-10-00721-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/c2c7a6fe5e11/jcm-10-00721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/e3c9e18f6538/jcm-10-00721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6199/7918460/c5cd660b9ec2/jcm-10-00721-g003.jpg

相似文献

1
Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.心脏代谢:健康与患病心脏之间的连锁谜题——治疗应用的新前沿
J Clin Med. 2021 Feb 12;10(4):721. doi: 10.3390/jcm10040721.
2
Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.靶向脂肪酸和碳水化合物氧化——缺血性和衰竭心脏的一种新型治疗干预措施。
Biochim Biophys Acta. 2011 Jul;1813(7):1333-50. doi: 10.1016/j.bbamcr.2011.01.015. Epub 2011 Jan 20.
3
Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.心肌代谢及其与心肌细胞收缩、生长和存活的相互作用。
Circ Res. 2013 Aug 16;113(5):603-16. doi: 10.1161/CIRCRESAHA.113.302095.
4
Nuclear receptor signaling and cardiac energetics.核受体信号传导与心脏能量代谢
Circ Res. 2004 Sep 17;95(6):568-78. doi: 10.1161/01.RES.0000141774.29937.e3.
5
Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.心力衰竭中的心肌能量底物代谢:从途径到治疗靶点
Curr Pharm Des. 2015;21(25):3654-64. doi: 10.2174/1381612821666150710150445.
6
Loss of Ptpmt1 limits mitochondrial utilization of carbohydrates and leads to muscle atrophy and heart failure in tissue-specific knockout mice.Ptpmt1 的缺失限制了线粒体对碳水化合物的利用,导致组织特异性敲除小鼠的肌肉萎缩和心力衰竭。
Elife. 2023 Sep 6;12:RP86944. doi: 10.7554/eLife.86944.
7
Emerging Roles of SIRT3 in Cardiac Metabolism.SIRT3在心脏代谢中的新作用。
Front Cardiovasc Med. 2022 Mar 18;9:850340. doi: 10.3389/fcvm.2022.850340. eCollection 2022.
8
Fatty acid oxidation in the heart.心脏中的脂肪酸氧化
J Cardiovasc Pharmacol. 1996;28 Suppl 1:S11-7. doi: 10.1097/00005344-199600003-00003.
9
The Regulation of Insulin-Stimulated Cardiac Glucose Transport via Protein Acetylation.通过蛋白质乙酰化对胰岛素刺激的心脏葡萄糖转运的调节
Front Cardiovasc Med. 2018 Jun 12;5:70. doi: 10.3389/fcvm.2018.00070. eCollection 2018.
10
Regulation of sarcolemmal transport of substrates in the healthy and diseased heart.健康和患病心脏中肌膜底物转运的调节。
Cardiovasc Drugs Ther. 2006 Dec;20(6):471-6. doi: 10.1007/s10557-006-0582-8.

引用本文的文献

1
Prenatal Bisphenol A Exposure Impairs Fetal Heart Development: Molecular and Structural Alterations with Sex-Specific Differences.产前双酚A暴露损害胎儿心脏发育:具有性别特异性差异的分子和结构改变
Antioxidants (Basel). 2025 Jul 14;14(7):863. doi: 10.3390/antiox14070863.
2
Specialized Pro-Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential.作为心脏保护新角色的特殊促消退介质:从炎症消退到治疗潜力
Acta Physiol (Oxf). 2025 Jul;241(7):e70062. doi: 10.1111/apha.70062.
3
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases.

本文引用的文献

1
The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.铁代谢的分子机制及其在心脏功能障碍和心脏保护中的作用。
Int J Mol Sci. 2020 Oct 24;21(21):7889. doi: 10.3390/ijms21217889.
2
In vitro ketone-supported mitochondrial respiration is minimal when other substrates are readily available in cardiac and skeletal muscle.在心脏和骨骼肌中,当其他底物容易获得时,体外酮支持的线粒体呼吸是最小的。
J Physiol. 2020 Nov;598(21):4869-4885. doi: 10.1113/JP280032. Epub 2020 Aug 19.
3
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control.
Metrnl:心血管和代谢疾病有前景的生物标志物和治疗靶点。
Cell Commun Signal. 2024 Aug 5;22(1):389. doi: 10.1186/s12964-024-01767-8.
4
The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failure.具有氧化还原活性的防御性硒蛋白 T 作为一种新型的应激感应蛋白,在心衰的病理生理学中发挥着关键作用。
J Transl Med. 2024 Apr 20;22(1):375. doi: 10.1186/s12967-024-05192-w.
5
Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity?抗肿瘤治疗相关性心脏毒性的远隔缺血预处理是否存在线粒体保护作用?
Curr Heart Fail Rep. 2024 Aug;21(4):292-304. doi: 10.1007/s11897-024-00658-w. Epub 2024 Mar 21.
6
Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review.导致曲美他嗪在竞技运动员中被滥用的生化方面:小型综述。
Int J Mol Sci. 2024 Jan 28;25(3):1605. doi: 10.3390/ijms25031605.
7
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer.线粒体功能障碍:心血管疾病与癌症的交汇点
J Transl Med. 2023 Sep 19;21(1):635. doi: 10.1186/s12967-023-04498-5.
8
Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience).ACE 基因多态性与支架类型(生物模拟,超顺,Xience)相关的支架内再狭窄。
Mol Biol Rep. 2023 Aug;50(8):6445-6455. doi: 10.1007/s11033-023-08554-7. Epub 2023 Jun 16.
9
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State.棕榈酸诱导的心脏脂肪毒性通过 SELENOT 的氧化还原活性基序通过改善线粒体功能和调节代谢状态得到缓解。
Cells. 2023 Mar 29;12(7):1042. doi: 10.3390/cells12071042.
10
Quercetin and Its Derivative Counteract Palmitate-Dependent Lipotoxicity by Inhibiting Oxidative Stress and Inflammation in Cardiomyocytes.槲皮素及其衍生物通过抑制心肌细胞氧化应激和炎症来抵抗棕榈酸诱导的脂毒性。
Int J Environ Res Public Health. 2023 Feb 16;20(4):3492. doi: 10.3390/ijerph20043492.
钠-葡萄糖协同转运蛋白 2 抑制剂:除血糖控制之外的心血管获益机制。
Nat Rev Cardiol. 2020 Dec;17(12):761-772. doi: 10.1038/s41569-020-0406-8. Epub 2020 Jul 14.
4
Epidemiology of heart failure.心力衰竭的流行病学。
Eur J Heart Fail. 2020 Aug;22(8):1342-1356. doi: 10.1002/ejhf.1858. Epub 2020 Jun 1.
5
Abnormalities of Skeletal Muscle, Adipocyte Tissue, and Lipid Metabolism in Heart Failure: Practical Therapeutic Targets.心力衰竭时骨骼肌、脂肪组织及脂质代谢异常:实用的治疗靶点
Front Cardiovasc Med. 2020 May 12;7:79. doi: 10.3389/fcvm.2020.00079. eCollection 2020.
6
Cardiac metabolism as a driver and therapeutic target of myocardial infarction.心肌梗死后的心脏代谢:驱动因素和治疗靶点
J Cell Mol Med. 2020 Jun;24(11):5937-5954. doi: 10.1111/jcmm.15180. Epub 2020 May 8.
7
Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction.维持糖尿病心肌病中的心肌葡萄糖利用可加速线粒体功能障碍。
Diabetes. 2020 Oct;69(10):2094-2111. doi: 10.2337/db19-1057. Epub 2020 May 4.
8
Pathogenesis of Mucopolysaccharidoses, an Update.黏多糖贮积症的发病机制:更新。
Int J Mol Sci. 2020 Apr 4;21(7):2515. doi: 10.3390/ijms21072515.
9
Enhancing Glycolysis Protects against Ischemia-Reperfusion Injury by Reducing ROS Production.增强糖酵解通过减少活性氧生成来预防缺血再灌注损伤。
Metabolites. 2020 Mar 30;10(4):132. doi: 10.3390/metabo10040132.
10
Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?顿抑心肌和冬眠心肌:近40年后我们进展如何?
J Am Heart Assoc. 2020 Feb 4;9(3):e015502. doi: 10.1161/JAHA.119.015502.